(KTIV) -- As states wait for approved COVID-19 vaccines from companies like Pfizer and Moderna, a new common treatment is coming soon that could help lower the number of hospitalizations.
Nebraska Director of Health, Dr. Gary Anthone says, on Nov. 9, Monoclonal Antibodies were authorized for use. He said the antibodies directly neutralize the virus and help prevent the progression of symptoms.
Dr. Anthone says early evidence has shown it could reduce the likelihood a patient would require hospitalization by up to 10%.
"So lets say you have 100 patients that you gave the monoclonal antibody infusion to, hopefully it can prevent 5 to 10 of those patients from ending up needing hospitalizations which would be a great thing at this point," said Dr. Anthone
Dr. Anthone said the antibodies would be administered through a single dose, likely through an IVV infusion.
Last night, Nebraska's total COVID-19 cases surpassed 100,000 as the state reported a record 3,440 new cases. Nebraska has had 101,601 cases since the pandemic began.
There were also eighteen new deaths reported Monday to give the state 797 deaths. The number of people hospitalized with the virus in the state also set a new record at 938.
Gov. Pete Ricketts has said that if that number continues to rise and approaches 1,200 -- when 25% of the hospitalized patients in the state have coronavirus -- he will impose additional restrictions to limit the spread of the virus.
To watch the Ricketts Tuesday news conference, click here.